N-(2,8-dimethyl-3-oxo-1-thia-4-azaspiro[4.5]decan-4-yl)-3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide
C25H28N4O4S2 — CID 154584462
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(2,8-dimethyl-3-oxo-1-thia-4-azaspiro[4.5]decan-4-yl)-3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide
N-(2,8-dimethyl-3-oxo-1-thia-4-azaspiro[4.5]decan-4-yl)-3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide (PubChem CID 154584462) has the molecular formula C25H28N4O4S2 and a molecular weight of 512.66 g/mol. Its IUPAC name is N-(2,8-dimethyl-3-oxo-1-thia-4-azaspiro[4.5]decan-4-yl)-3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide.
Molecular Properties
| Compound Name | N-(2,8-dimethyl-3-oxo-1-thia-4-azaspiro[4.5]decan-4-yl)-3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide |
|---|---|
| PubChem CID | 154584462 |
| Molecular Formula | C25H28N4O4S2 |
| Molecular Weight | 512.66 g/mol |
| Exact Mass | 512.16 |
| IUPAC Name | N-(2,8-dimethyl-3-oxo-1-thia-4-azaspiro[4.5]decan-4-yl)-3-phenyl-5-sulfamoyl-1H-indole-2-carboxamide |
| SMILES | CC1CCC2(CC1)SC(C)C(=O)N2NC(=O)c1[nH]c2ccc(S(N)(=O)=O)cc2c1-c1ccccc1 |
| InChI | InChI=1S/C25H28N4O4S2/c1-15-10-12-25(13-11-15)29(24(31)16(2)34-25)28-23(30)22-21(17-6-4-3-5-7-17)19-14-18(35(26,32)33)8-9-20(19)27-22/h3-9,14-16,27H,10-13H2,1-2H3,(H,28,30)(H2,26,32,33) |
| InChIKey | NWIPDBQNAZXVDM-UHFFFAOYSA-N |
| XLogP | 4.00 |
| TPSA | 125.36 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 512.66 |
| LogP ≤ 5 | 4.00 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154584462 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.